Gritstone bio (GRTSQ)
Company Profile
Quarter (USD) | Mar 24 | Dec 23 | Sep 23 | Jun 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 48.93 mm | 48.93 mm | 48.93 mm | 48.93 mm | 48.93 mm | 48.93 mm |
Cash burn (monthly) | 7.21 mm | 463.58 k | 13.27 mm | 12.05 mm | 11.19 mm | 9.59 mm |
Cash used (since last report) | 63.36 mm | 4.07 mm | 116.52 mm | 105.83 mm | 98.27 mm | 84.26 mm |
Cash remaining | -14.43 mm | 44.86 mm | -67.59 mm | -56.90 mm | -49.34 mm | -35.33 mm |
Runway (months of cash) | -2.0 | 96.8 | -5.1 | -4.7 | -4.4 | -3.7 |
13F holders | Current |
---|---|
Total holders | 79 |
Opened positions | 30 |
Closed positions | 36 |
Increased positions | 12 |
Reduced positions | 21 |
13F shares | Current |
---|---|
Total value | 24.01 bn |
Total shares | 47.04 mm |
Total puts | 168.00 k |
Total calls | 1.46 mm |
Total put/call ratio | 0.1 |
Largest owners | Shares | Value |
---|---|---|
Redmile | 5.11 mm | $3.16 bn |
Vanguard | 4.64 mm | $2.87 bn |
MS Morgan Stanley | 4.45 mm | $2.75 bn |
Frazier Life Sciences Public Fund | 4.13 mm | $0.00 |
Versant Venture Management | 3.56 mm | $2.20 bn |
Alyeska Investment | 3.46 mm | $2.14 bn |
Deutsche Bank AG - Registered Shares | 3.23 mm | $2.00 bn |
Artal | 3.03 mm | $1.87 bn |
Versant Venture Capital V | 2.90 mm | $0.00 |
FMR | 1.61 mm | $993.81 mm |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
18 Dec 24 | Vassiliki Economides | Common Stock | Sell | Dispose S | No | No | 0.015 | 12,000 | 180.00 | 250,437 |
24 Jun 24 | Allen Andrew R | Common Stock | Gift | Dispose G | No | No | 0 | 325,000 | 0.00 | 985,360 |
24 Jun 24 | Allen Andrew R | Common Stock | Gift | Dispose G | Yes | No | 0 | 325,000 | 0.00 | 1,124,275 |
17 Jun 24 | Naiyer Rizvi | Stock Option Common Stock | Grant | Acquire A | No | No | 0.76 | 51,800 | 39.37 k | 51,800 |
17 Jun 24 | Agarwal Shefali | Stock Option Common Stock | Grant | Acquire A | No | No | 0.76 | 51,800 | 39.37 k | 51,800 |
17 Jun 24 | Webster Stephen W | Stock Option Common Stock | Grant | Acquire A | No | No | 0.76 | 7,379 | 5.61 k | 7,379 |